Anastrozole tablets are used for the treatment of postmenopausal women diagnosed with hormone-receptor-positive, early-stage breast cancer after surgery or postmenopausal women diagnosed with advanced-stage or metastatic hormone-receptor-positive breast cancer. Anastrozole oral tablet is available as a generic drug and as a brand-name drug. The brand name for Anastrozole tablet is Arimidex. Tablet is the only formulation available for anastrozole. The dose of anastrozole is given in 1 mg tablet taken once a day. Anastrozole was approved in 1995 for medical use in the U.S.
Market Dynamics
Various benefits offered by anastrozole tablets is expected to boost the anastrozole tablets market growth over the forecast period. Anastrozole is designed to reduce the incidence of estrogen-sensitive breast cancers. It does so by inhibiting aromatase, an enzyme crucial to the production of the hormone. For instance, according to a research study published in 2015 in The Lancet Journal, anastrozole reduces breast cancer risk by 50% in older and in menopausal women. This research study involved almost 4,000 women from cancer centers in 18 countries. All were postmenopausal and were deemed to be at high risk of breast cancer. The study was funded by Cancer Research U.K., the National Health and Medical Research Council Australia, and drug makers Sanofi-Aventis and AstraZeneca Plc.
However, there are several side effects associated with anastrozole tablets. For instance, women under anastrozole treatment often experience nausea, vomiting, upset stomach, loss of appetite, body aches and pains (back pain, bone pain, joint pain or stiffness), breast swelling/tenderness/pain, headache, dry mouth, dizziness, trouble sleeping (insomnia), tiredness, weakness, hot flashes, vaginal bleeding, weight changes, depression, mood changes, numbness or weakness in your hand or wrist. Furthermore, there is huge population of breast cancer patients who opt for surgery and other treatment options. Such factors are expected to hinder the anastrozole tablets market growth in the near future.
Key features of the study
• This report provides in-depth analysis of the global anastrozole tablets market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global anastrozole tablets market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include AstraZeneca Plc, Zydus Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Natco Pharma, Fresenius Kabi, Accord Healthcare Ltd., Mylan N.V., Cipla Ltd., Apotex Inc., Zhejiang Hisun, Chongqing Huapont Pharmaceutical Co., Ltd., Zhejiang Wansheng Pharmaceutical Co. Ltd., and Yangtze River Pharmaceutical Group
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global anastrozole tablets market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for anastrozole tablets market, research and consulting firms, new entrants, and financial analysts
Market Segmentation
• By Type
o Branded Anastrozole Tablets
o Generic Anastrozole Tablets
• By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region
o North America
 U.S.
 Canada
o Latin America
 Brazil
 Mexico
 Argentina
 Rest of Latin America
o Europe
 Germany
 U.K.
 France
 Italy
 Spain
 Russia
 Rest of Europe
o Asia Pacific
 China
 India
 Japan
 Australia
 South Korea
 ASEAN
 Rest of Asia Pacific
o Middle East
 GCC
 Israel
 Rest of Middle East
o Africa
 South Africa
 Central Africa
 North Africa
• Key Players
o AstraZeneca Plc
o Zydus Pharmaceuticals
o Teva Pharmaceutical Industries Ltd.
o Hikma Pharmaceuticals
o Natco Pharma
o Fresenius Kabi
o Accord Healthcare Ltd.
o Mylan N.V.
o Cipla Ltd.
o Apotex Inc.
o Zhejiang Hisun
o Chongqing Huapont Pharmaceutical Co.Ltd.
o Zhejiang Wansheng Pharmaceutical Co. Ltd.
o Yangtze River Pharmaceutical Group

Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
 Market Definition and Scope
o Executive Summary
 Market Snippet, By Type
 Market Snippet, By Distribution Channel
 Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
 Drivers
 Restraints
 Market Opportunities
o Impact Analysis
o Market Trends
o Regulatory Scenario
o Reimbursement Scenario
o New Product Launches/Approvals
o Collaborations & Partnerships
o Mergers & Acquisitions
o PEST Analysis
4. Global Anastrozole Tablets Market, By Type, 2021 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026, and 2033 (%)
 Y-o-Y Growth Analysis, 2022-2033
 Segment Trends
o Branded Anastrozole Tablets
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Generics Anastrozole Tablets
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Anastrozole Tablets Market, By Distribution Channel, 2021 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, 2026, and 2033 (%)
 Y-o-Y Growth Analysis, 2022-2033
 Segment Trends
o Hospital Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Retail Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Online Pharmacies
 Introduction
 Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Anastrozole Tablets Market, By Region, 2021 – 2033, (USD Bn)
o Introduction
 Market Share Analysis, By Region, 2026 and 2033 (%)
 Y-o-Y Growth Analysis, By Region, 2022-2033
 Regional Trends
o North America
 Market Size and Forecast, By Type, 2021-2033, (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
 Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o U.S.
o Canada
o Europe
 Market Size and Forecast, By Type, 2021-2033, (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
 Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
 Market Size and Forecast, By Type, 2021-2033, (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
 Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
 Market Size and Forecast, By Type, 2021-2033, (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
 Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
 Market Size and Forecast, By Type, 2021-2033, (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
 Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
o Middle East
 Market Size and Forecast, By Type, 2021-2033, (USD Bn)
 Market Size and Forecast, By Distribution Channel, 2021-2033, (USD Bn)
 Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
7. Competitive Landscape
o Company Profiles
 AstraZeneca Plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Zydus Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Teva Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Hikma Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Natco Pharma
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Fresenius Kabi
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Accord Healthcare Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Mylan N.V.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Cipla Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Apotex Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Zhejiang Hisun
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Chongqing Huapont Pharmaceutical Co., Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Zhejiang Wansheng Pharmaceutical Co. Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
 Yangtze River Pharmaceutical Group
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
8. Section
o References
o Research Methodology
o About us and Sales Contact